Evidence map›Paper›PMID 40422329›Full record

ReviewGels (Basel, Switzerland)2025

From Basic to Breakthroughs: The Journey of Microfluidic Devices in Hydrogel Droplet Generation.

Gabriela Hinojosa-Ventura, José Manuel Acosta-Cuevas, Carlos Arnulfo Velázquez-Carriles, Diego E Navarro-López, Miguel Ángel López-Alvarez, Néstor D Ortega-de la Rosa, Jorge Manuel Silva-Jara

Abstract readReview
In one paragraph

Review in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Alginate Sphere-Based Soft Actuators.Gels (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gabriela Hinojosa-VenturaDepartamento de Farmacobiología, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara 44430, Mexico.ORCID 0009-0005-0869-2317
José Manuel Acosta-CuevasDepartamento de Ingeniería Química, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara 44430, Mexico.
Carlos Arnulfo Velázquez-CarrilesDepartamento de Ingeniería Biológica, Sintética y de Materiales, Centro Universitairo de Tlajomulco, Universidad de Guadalajara, Tlajomulco de Zúñiga 45641, Mexico.
Diego E Navarro-LópezEscuela de Ingeniería y Ciencias, Tecnológico de Monterrey, Zapopan 45138, Mexico.ORCID 0000-0001-6810-8032
Miguel Ángel López-AlvarezDepartamento de Ingeniería Mecánica, Universidad de Guadalajara, Guadalajara 44430, Mexico.ORCID 0000-0001-6372-5728
Néstor D Ortega-de la RosaDepartamento de Ingeniería Biológica, Sintética y de Materiales, Centro Universitairo de Tlajomulco, Universidad de Guadalajara, Tlajomulco de Zúñiga 45641, Mexico.ORCID 0000-0002-8574-8266
Jorge Manuel Silva-JaraDepartamento de Farmacobiología, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara 44430, Mexico.ORCID 0000-0001-8742-6247

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydrogel particles are essential in biological applications because of their distinctive capacity to retain water and encapsulate active molecules within their three-dimensional structure. Typical particle sizes range from nanometers (10-500 nm) to micrometers (1-500 µm), depending on the specific application and method of preparation. These characteristics render them optimal carriers for the administration of active compounds, facilitating the regulated and prolonged release of pharmaceuticals, including anticancer agents, antibiotics, and therapeutic proteins. Hydrogel particles can exhibit various morphologies, including spherical, rod-shaped, disk-shaped, and core-shell structures. Each shape offers distinct advantages, such as improved circulation time, targeted drug delivery, or enhanced cellular uptake. Additionally, hydrogel particles can be engineered to respond to various stimuli, such as temperature, pH, light, magnetic fields, and biochemical signals. Furthermore, their biocompatibility and capacity to acclimate to many biological conditions make them appropriate for sophisticated applications, including gene treatments, tissue regeneration, and cell therapies. Microfluidics has transformed the creation of hydrogel particles, providing precise control over their dimensions, morphology, and stability. This technique facilitates reproducible and highly efficient production, reducing reagent waste and optimizing drug encapsulation. The integration of microfluidics with hydrogels provides opportunities for the advancement of creative and effective solutions in contemporary medicine.

Indexed as

biomedical applicationshydrogelsmaterials for microfluidic devicesmicrofluidic devicesmicrofluidic methodsmicrohydrogels

Identifiers

PMID40422329
PMCPMC12110922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.